Literature DB >> 27468082

Interference of New Drugs with Compatibility Testing for Blood Transfusion.

Michael F Murphy1, Larry J Dumont2, Andreas Greinacher3.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27468082     DOI: 10.1056/NEJMc1515969

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Daratumumab Interference in Pretransfusion Testing Is Overcome by Addition of Daratumumab Fab Fragments to Patients' Plasma.

Authors:  Egon Werle; Josefin Ziebart; Eleonora Wasmund; Kristin Eske-Pogodda
Journal:  Transfus Med Hemother       Date:  2019-03-12       Impact factor: 3.747

Review 2.  Antibody-Based Treatment Approaches in Multiple Myeloma.

Authors:  Hitomi Hosoya; Surbhi Sidana
Journal:  Curr Hematol Malig Rep       Date:  2021-03-17       Impact factor: 3.952

3.  Transfusion management for patients taking an anti-CD38 monoclonal antibody.

Authors:  Carolina Bonet Bub; Isabel Nagle Dos Reis; Maria Giselda Aravechia; Leandro Dinalli Santos; Eduardo Peres Bastos; José Mauro Kutner; Lilian Castilho
Journal:  Rev Bras Hematol Hemoter       Date:  2017-11-26

Review 4.  Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab.

Authors:  Marilyn T Nedumcheril; Robert A DeSimone; Sabrina E Racine-Brzostek; Ok Kyong Chaekal; Ljiljana V Vasovic
Journal:  J Blood Med       Date:  2021-05-25

5.  Role of daratumumab in transfusion medicine: a must know entity.

Authors:  Rajeswari Subramaniyan; Ramaprabahari Satheshkumar; Karishma Rosann Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2017-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.